Ignite Creation Date:
2025-12-25 @ 4:34 AM
Ignite Modification Date:
2026-03-01 @ 6:11 AM
Study NCT ID:
NCT02008318
Status:
COMPLETED
Last Update Posted:
2019-09-11
First Post:
2013-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Galunisertib in Participants With Myelodysplastic Syndromes
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-06
First Submit QC Date:
None
Study First Post Date:
2013-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-21
Results First Submit QC Date:
None
Results First Post Date:
2019-03-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-08-16
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-08-28
Last Update Post Date:
2019-09-11
Last Update Post Date Type:
ACTUAL